SYNTHESIS AND IN VITRO AND IN VIVO EVALUATION OF A 99MTC-LABELED LUTEINIZING HORMONE-RELEASING HORMONE (LHRH) PEPTIDE AS A BREAST CANCER IMAGING AGENT

被引:0
|
作者
Okarvi, S. M. [1 ]
AlJammaz, I. [1 ]
机构
[1] King Faisal Specialist Hosp & Res Ctr, Cyclotron & Radiopharmaceut Dept, Riyadh 11211, Saudi Arabia
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S178 / S179
页数:2
相关论文
共 50 条
  • [21] Longitudinal MicroSPECT/CT Imaging and pharmacokinetics of synthetic luteinizing hormone-releasing hormone (LHRH) vaccine in rats
    Chang, Chih-Hsien
    Hsu, Wei-Chuan
    Wang, Chang-Yi
    Jan, Meei-Ling
    Tsai, Tung-Hu
    Lee, Te-Wei
    Lynn, Shu-Gene
    Yeh, Chung-Hsin
    Chang, Tsui-Jung
    ANTICANCER RESEARCH, 2007, 27 (5A) : 3251 - 3257
  • [22] 99mTc-labeled lactam bridge-cyclized α-melanocyte stimulating hormone peptide analogue as a specific melanoma imaging agent
    Texeira, Vania
    Fernandez, Marcelo
    Moreno, Maria
    Porcal, Williams
    Quinn, Thomas
    Gambini, Juan
    Cabral, Pablo
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [23] Future possibilities in the prevention of breast cancer: Luteinizing hormone-releasing hormone agonists
    Darcy V Spicer
    Malcolm C Pike
    Breast Cancer Research, 2
  • [24] Future possibilities in the prevention of breast cancer - Luteinizing hormone-releasing hormone agonists
    Spicer, DV
    Pike, MC
    BREAST CANCER RESEARCH, 2000, 2 (04): : 264 - 267
  • [25] Synthesis and evaluation of a 99mTc-labeled tubulin-binding agent for tumor imaging
    Erfani, Mostafa
    Shamsaei, Mojtaba
    Mohammadbaghery, Faiyaz
    Shirmardi, Seyed Pezhman
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2014, 57 (06): : 419 - 424
  • [26] Synthesis, characterization and stability of a luteinizing hormone-releasing hormone (LHRH)-functionalized poly(amidoamine) dendrimer conjugate
    Bi, Xiangdong
    Shi, Xiangyang
    Baker, James R., Jr.
    JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2008, 19 (01) : 131 - 142
  • [27] Effect of luteinizing hormone-releasing hormone (LHRH) analogue treatment on a cytokine profile in prostate cancer patients
    Kaczmarek, Piotr
    Pokoca, Lech
    Niemirowicz, Jerzy
    Majewska, Ewa
    Baj, Zbigniew
    PHARMACOLOGICAL REPORTS, 2008, 60 (03) : 399 - 403
  • [28] Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer
    Tan, Sing-Huang
    Wolff, Antonio C.
    CLINICAL BREAST CANCER, 2007, 7 (06) : 455 - 464
  • [29] Testosterone Suppression with Luteinizing Hormone-Releasing Hormone (LHRH) Agonists in Patients Receiving Radiotherapy for Prostate Cancer
    Wilke, Derek
    Patil, Nikhilesh
    Hollenhorst, Helmut
    Bowes, David
    Rutledge, Robert
    Ago, Casely
    PHARMACOTHERAPY, 2018, 38 (03): : 327 - 333
  • [30] Luteinizing Hormone-Releasing Hormone (LHRH) Expression in Male Meningiomas (MM)-Implications for Treatment of Coexisting Prostate Cancer with LHRH Agonists
    Kulkarni, R. S.
    Reid-Nicholson, M. D.
    Terris, M. K.
    Sharma, S.
    Ramalingam, P.
    LABORATORY INVESTIGATION, 2009, 89 : 176A - 176A